| mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
0.004 |
0.9 |